Cardinal Partners
Venture capitalPrinceton · Seed–Growth · 4 people tracked
Investment thesis
Cardinal Partners targets early and growth stage healthcare companies driving innovation in care delivery, accessibility, and cost reduction across evolving healthcare systems, insurance, and regulatory landscapes. The firm leverages extensive experience across multiple business cycles and strong networks in academic, clinical, and industry communities to build durable, valuable companies with superior returns.
Source: firm website, verified Jul 21, 2026.
Team · 4 people
from the firm's websiteWhat they invest in
from 12 of 17 portfolio companiesHealthtech ×9Medical Devices ×7Biotech ×6Digital Health ×4Enterprise Software ×3AI & Machine Learning ×2Data & Infrastructure ×1Deep Tech ×1
HQs:United States×3Denmark×1
Investments · 17 tracked
founders shown can be your intro pathAlkermes develops pharmaceutical medicines for psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders. The company leverages neuroscience expertise to create treatments for patients with complex conditions that are traditionally underserved.
BiotechHealthtechMedical Devices
Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.
BiotechDigital HealthMedical Devices
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease. The company leverages a proprietary discovery platform targeting immune-mediated disorders in pulmonary and systemic conditions.
BiotechHealthtechMedical Devices
Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors. The system is designed for nursing staff, pharmacists, IT departments, clinical engineers, and anesthesia professionals in healthcare facilities.
HealthtechMedical Devices
Intelerad provides medical imaging software and healthcare IT solutions that connect physicians across the patient journey. The company was acquired by GE HealthCare.
Enterprise SoftwareHealthtechMedical Devices
Prealize develops AI and machine learning solutions for healthcare providers and health plans to enable proactive, prediction-driven care rather than reactive treatment. The company serves health systems and insurers seeking to optimize clinical outcomes and operations through predictive analytics.
AI & Machine LearningDigital HealthHealthtechInsurTechStanford, US
Dr. Nigam ShahDr. Arnold Milstein
Lundbeck is a global pharmaceutical company specializing in researching, developing, manufacturing, and commercializing medications for brain diseases and neurological conditions. The company serves patients and healthcare providers worldwide across the neuroscience field.
BiotechHealthtechMedical DevicesCopenhagen, DK
Privia Health operates a network of physician practices organized for value-based care delivery, supporting independent practices and physicians across multiple specialties while maintaining clinical autonomy. The company works to improve patient outcomes and practice economics through its capital-efficient model.
Data & InfrastructureDigital HealthEnterprise SoftwareHealthtechSaaS<UNKNOWN>
Zelis provides financial technology solutions purpose-built for healthcare payers, providers, and members, with capabilities spanning network management, member engagement, claims optimization, payments, and communications. The platform helps optimize costs and reduce administrative burden in the healthcare financial system.
Enterprise SoftwareFintechHealthtech
Teladoc Health operates a virtual care platform connecting patients with care providers for medical care, mental health, and chronic disease management services. The company serves health plans, employers, and hospital systems across the United States.
Digital HealthHealthtechMental Health
Verastem Oncology is a biopharmaceutical company that discovers and develops drugs to treat cancer patients. The company focuses on oncology therapeutics including small molecules and monoclonal antibodies targeting pathways such as RAS, KRAS, and immune modulation.
BiotechMedical Devices
Robert Weinberg
Vividion Therapeutics develops small molecule therapeutics using a covalent-first chemoproteomics approach to identify and target previously undruggable proteins. The company operates across the full drug development spectrum from discovery to clinical development.
AI & Machine LearningBiotechDeep Tech
Ben Cravatt(Scientific Founder)Phil Baran(Scientific Founder)Jin-Quan Yu(Scientific Founder)
Frequently asked questions
- What stage does Cardinal Partners invest at?
- Cardinal Partners invests at the Seed, Series A, Series B, Growth stages.
- What sectors does Cardinal Partners focus on?
- Cardinal Partners focuses on Biotech, Healthtech, Medical Devices.
- Where is Cardinal Partners located?
- Cardinal Partners is headquartered in Princeton, US.
- Does Cardinal Partners lead rounds?
- Yes, Cardinal Partners leads investment rounds.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.